Immunomedics Announces Promising Data of Sacituzumab Govitecan in Estrogen Receptor-Positive Metastatic Breast Cancer

World News: . []

MORRIS PLAINS NJ May 16 2018 GLOBE NEWSWIRE) -- NASDAQIMMU Immunomedics or the Company a science-based and innovation-focused biopharmaceutical company committed to the development and worldwide commercialization of its uni que and...

More news and information about Immunomedics, Inc.

Published By:

Globe Newswire: 22:01 GMT Wednesday 16th May 2018

Published: .

Search for other references to "immunomedics" on SPi News

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us

Advertising on SPi News: Information For Advertisers